Rocket Lab's Order Book Swells to $3.57 Billion as Neutron Slips to 2027
Published on 11/11/2026 at 15:01 | Editorial boerse-global.de
Rocket Lab's stock rose 7.0% following the release of quarterly results, but the headline number that matters for anyone weighing a position sits further down the page: the first flight of the Neutron rocket is now targeted for 2027 at the earliest. The company was explicit that this is a best-case window, not a committed launch date.
The quarter itself was strong on paper. Revenue hit a record $268 million for the third quarter of 2026, up 73% year over year. Backlog climbed roughly 52% from the prior quarter to about $3.6 billion, and Rocket Lab also reported positive GAAP operating cash flow of $7.2 million. Reuters noted the share gains came despite a loss per share that came in wider than analysts had expected.
New Business Pours In Across Two Segments
Fresh contract signings added around $1 billion in launch agreements during the reporting period, while the Space Systems division booked $470 million in deals. The backlog, measured precisely, stood at $3.57 billion at quarter-end. Management expects 32.9% of that total to convert into revenue within twelve months.
That conversion rate is the number to watch. The order book spans 117 launches and more than 55 spacecraft, giving Rocket Lab booked work on both the launch and satellite sides of its business. Breadth of that kind supports the growth case — provided both segments execute without major slippage.
For the fourth quarter of 2026, Rocket Lab guided to revenue of $270 million to $290 million, alongside an adjusted EBITDA loss of $14 million to $20 million. Hitting the top end of that range would reinforce the expansion story, so long as it doesn't come at the cost of deeper losses.
Should investors sell immediately? Or is it worth buying Rocket Lab?
Neutron's Price Tag Rises With the Stakes
Eight Neutron launches were signed in the third quarter, worth roughly $515 million. Several of those contracts carry a higher base price of $70 million per flight — a signal that customers will pay up for the vehicle, if it flies on schedule.
That commercial foundation is real. The risk sits on the technical side. Defects discovered in the rocket's tank have left the exact debut date open, and development spending is expected to stay elevated through the first flight. The longer those costs run, the more the higher contract prices get eaten away before a single Neutron reaches orbit.
Financing is in place, at least. An at-the-market equity program completed in the third quarter of 2026 raised $2.4 billion, which the company says fully funds the planned acquisition of Iridium. For existing shareholders, though, that capital comes with dilution — a larger corporate revenue base now has to be spread across more shares, raising the bar for per-share growth.
Mars Probes Hit Their Mark
Away from the launch pad, Rocket Lab reported successful propulsion maneuvers for its two ESCAPADE spacecraft, built for NASA and UC Berkeley. The burns took place on Saturday and Monday, putting the probes on course for Mars, with orbital insertion slated for September 2027.
On the analyst side, KeyBanc reiterated an "Overweight" rating with a $100 price target, according to media reports. ARK Invest, meanwhile, picked up roughly $3.4 million worth of Rocket Lab shares on Tuesday, spread across several of its funds — a modest but notable vote of confidence from an institutional buyer.
What the February Report Has to Show
The next hard checkpoint arrives in February 2027, when fourth-quarter results are due. That release should offer a clean read on whether revenue is tracking the backlog and whether spending stays contained. Neutron tank tests are scheduled for the first quarter of 2027; success there would chip away at the technical uncertainty, while further problems would push the backlog's revenue conversion further into the future.
The bull case rests on a simple chain: a $3.57 billion order book, a funded balance sheet, and a rocket that eventually commands $70 million a flight. The bear case is equally simple — a 2027 debut that keeps slipping, development costs that keep climbing, and a share count that keeps growing. Which argument wins depends less on the backlog than on how reliably Rocket Lab turns it into delivered hardware.
Ad
Rocket Lab Stock: New Analysis - 11 November
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
